ProtonDx
Certainty in Testing Times
Rapid, portable, and accurate diagnostics, where you need it.
ProtonDx is launching a series of cutting‑edge diagnostic tools founded on a decade of research and development at Imperial College London.
Our vision is to develop ultra‑rapid, extremely precise, molecular testing for everyone at the point‑of‑need.
Dragonfly combines portability, speed, high sensitivity, high specificity, and convenience to differentiate and detect multiple pathogens from a single sample in less than 30 minutes.
High quality DNA and RNA samples are extracted from nasopharyngeal swabs and prepared for testing with minimal handling, providing results equivalent to the ‘gold standard’ polymerase chain reaction test (PCR) at point‑of‑need. In addition, the Dragonfly platform provides confidence that the patient sample has been taken and tested correctly.
Dragonfly test panels are available to detect a variety of pathogens.
The Dragonfly system is a CE‑marked in vitro diagnostic medical device and complies with the current European In‑vitro Diagnostic Devices Directive (IVDD 98/79/EC).
The latest news of Dragonfly being used at the Commonwealth Games 2022 can be found here.
Certainty in testing and confidence in our daily life.